Cipla has launched Yurpeak, a once-weekly injectable therapy for obesity and type 2 diabetes. The medicine will be available nationwide, supporting patients with convenient dosing and comprehensive guidance.
Cipla has launched Yurpeak, a once-weekly injectable therapy for obesity and type 2 diabetes. The medicine will be available nationwide, supporting patients with convenient dosing and comprehensive guidance.